Corcept Therapeutics Income Statement (2010-2026) | CORT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	91.59M	96.13M	98.82M	93.69M	103.39M	101.73M	103.06M	105.65M	117.72M	123.60M	135.41M	146.81M	163.80M	182.55M	181.89M	157.21M	194.43M	207.64M	202.12M	164.90M
Cost of Revenue (Quarter)	1.38M	1.27M	1.35M	1.25M	1.32M	1.34M	1.48M	1.39M	1.57M	1.65M	1.88M	2.54M	2.52M	2.87M	2.96M	2.40M	3.43M	4.60M	2.54M	2.88M
Gross Profit (Quarter)	90.20M	94.86M	97.47M	92.44M	102.07M	100.39M	101.58M	104.27M	116.14M	121.96M	133.53M	144.27M	161.27M	179.68M	178.93M	154.81M	191.00M	203.04M	199.58M	162.02M
Operating items
Research & Development (Quarter)	28.23M	28.09M	28.52M	28.12M	32.83M	33.29M	36.75M	40.85M	43.28M	45.52M	54.71M	58.51M	58.74M	59.34M	70.30M	60.73M	60.47M	68.85M	64.86M	66.27M
Selling, General & Administrative (Quarter)	30.03M	30.53M	32.28M	37.55M	37.81M	35.16M	42.32M	48.56M	43.28M	45.26M	47.15M	56.27M	66.94M	73.75M	83.37M	90.66M	103.85M	123.98M	130.24M	145.36M
Other Operating Expenses (Quarter)	1.38M	1.27M	1.35M	1.25M	1.32M	1.34M	1.48M	1.39M	1.57M	1.65M	1.88M	2.54M	2.52M	2.87M	2.96M	2.40M	3.43M	4.60M	2.54M	2.88M
Operating Expenses (Quarter)	59.65M	59.90M	62.16M	66.92M	71.95M	69.79M	80.56M	90.80M	88.13M	92.42M	103.74M	117.31M	128.20M	135.95M	156.63M	153.80M	167.75M	197.42M	197.64M	214.50M
Operating Income (Quarter)	31.94M	36.23M	36.66M	26.77M	31.43M	31.93M	22.50M	14.85M	29.58M	31.18M	31.67M	29.50M	35.59M	46.60M	25.26M	3.42M	26.68M	10.22M	4.49M	-49.60M
EBIT (Quarter)	31.94M	36.23M	36.66M	26.77M	31.43M	31.93M	22.50M	14.85M	29.58M	31.18M	31.67M	29.50M	35.59M	46.60M	25.26M	3.42M	26.68M	10.22M	4.49M	-49.60M
Non-operating items
Interest & Investment Income (Quarter)
Non Operating Income (Quarter)	0.11M	0.07M	0.07M	0.08M	0.63M	1.07M	1.78M	3.58M	3.35M	5.21M	5.14M	5.49M	6.00M	6.34M	6.70M	6.20M	5.02M	5.02M	5.42M	4.89M
Net income details
EBT (Quarter)	32.05M	36.30M	36.74M	26.85M	32.06M	33.00M	24.28M	18.43M	32.93M	36.38M	36.81M	34.99M	41.60M	52.94M	31.96M	9.62M	31.69M	15.24M	9.91M	-44.72M
Tax Provisions (Quarter)	5.50M	5.83M	4.69M	4.05M	4.65M	-1.60M	7.67M	2.60M	5.40M	5.01M	5.45M	7.23M	6.10M	5.70M	1.21M	-10.93M	-3.46M	-4.42M	-14.39M	-13.00M
Profit After Tax (Quarter)	26.52M	30.47M	32.05M	22.80M	27.41M	34.61M	16.60M	15.88M	27.53M	31.38M	31.36M	27.76M	35.49M	47.21M	30.75M	20.55M	35.15M	19.67M	24.29M	-31.76M
Income from Continuing Operations (Quarter)	26.55M	30.47M	32.04M	22.80M	27.41M	34.61M	16.60M	15.83M	27.53M	31.38M	31.36M	27.76M	35.50M	47.24M	30.75M	20.55M	35.15M	19.67M	24.30M	-31.71M
Consolidated Net Income (Quarter)	26.55M	30.47M	32.04M	22.80M	27.41M	34.61M	16.60M	15.83M	27.53M	31.38M	31.36M	27.76M	35.50M	47.24M	30.75M	20.55M	35.15M	19.67M	24.30M	-31.71M
Income towards Parent Company (Quarter)	26.55M	30.47M	32.04M	22.80M	27.41M	34.61M	16.60M	15.83M	27.53M	31.38M	31.36M	27.76M	35.50M	47.24M	30.75M	20.55M	35.15M	19.67M	24.30M	-31.71M
Net Income towards Common Stockholders (Quarter)	26.52M	30.47M	32.05M	22.80M	27.40M	34.55M	16.53M	15.81M	27.36M	31.17M	31.14M	27.51M	35.12M	46.69M	30.39M	20.29M	34.61M	19.36M	23.90M	-31.20M
Additional items
EPS (Basic) (Quarter)	0.23	0.26	0.28	0.22	0.26	0.32	0.15	0.15	0.27	0.31	0.30	0.27	0.34	0.45	0.29	0.19	0.33	0.19	0.24	-0.30
EPS (Weighted Average and Diluted) (Quarter)	0.21	0.24	0.26	0.20	0.24	0.30	0.14	0.14	0.25	0.28	0.28	0.25	0.32	0.41	0.25	0.17	0.29	0.16	0.20	-0.30
Shares Outstanding (Weighted Average) (Quarter)	116.56M	115.79M	115.65M	106.01M	106.29M	107.12M	106.79M	107.89M	104.91M	103.93M	103.56M	102.79M	102.95M	103.09M	103.23M	104.11M	104.11M	103.92M	103.86M	104.44M
Shares Outstanding (Diluted Average) (Quarter)	128.20M	127.17M	125.96M	115.04M	115.22M	115.82M	115.97M	115.42M	112.49M	112.05M	111.74M	109.92M	110.55M	113.72M	113.48M	119.82M	120.48M	119.98M	119.99M	104.44M
EBITDA (Quarter)	26.49M	30.37M	31.71M	21.67M	31.43M	31.93M	22.50M	14.85M	29.58M	31.18M	31.67M	29.50M	35.59M	46.60M	25.26M	3.42M	26.68M	10.22M	4.49M	-49.60M
Interest Expenses (Quarter)
Tax Rate (Quarter)	17.16%	16.07%	12.78%	15.09%	14.50%	-4.86%	31.61%	14.10%	16.40%	13.76%	14.82%	20.66%	14.66%	10.77%	3.80%	-113.63%	-10.91%	-29.03%	-145.20%	29.07%

Research Tools

Corcept Therapeutics Income Statement (2010-2026) | CORT

Create an account

Sign In

Reset Password